TABLE 2

Clinical Data, 18F-FDG Avidity, and Final Diagnosis of Splenic Lesions in Patients Without Known Malignancy (Group B)

Patient no.Age (y)SexClinical indication18F-FDG avidityMethod of diagnosisFinal diagnosis
189MAbdominal pain; CT lesion+SPL FNAGastric cancer
218FAbdominal pain; CT lesion+SurgeryBrucellosis
352MAbdominal pain; CT lesions+LN BxLymphoma
466MIncidental US finding+SPL FNALymphoma
555FIncidental CT finding+Lung BxSarcoidosis
665MIncidental CT finding+SPL FNALymphoma
769FIncidental CT finding; previous malaria+SurgeryLymphoma
840FIncidental US finding+SurgeryLymphoma
966MIncidental CT finding+SPL FNALymphoma
1059MAbdominal pain; CT lesions+SurgeryLymphoma
1162FIncidental CT findingC and I F/UNED
1233MIncidental US findingC and I F/UNED
1353MIncidental US findingC and I F/UNED
1455MIncidental CT findingC and I F/UNED
1548FIncidental US findingC and I F/UNED
1658MIncidental US findingC and I F/UNED
1748MIncidental CT findingC and I F/UNED
1859FIncidental US findingC and I F/UNED
1962MIncidental CT findingC and I F/UNED
2065MIncidental US findingC and I F/UNED
  • SPL = spleen; FNA = fine-needle aspiration; LN = lymph node; Bx = biopsy; US = ultrasound; C and I F/U = clinical and imaging follow-up; NED = no evidence of malignant disease on imaging work-up and stability of lesion on follow-up imaging.